Blood Cancer Discovery | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
Alerts
News
Cancer Hallmarks
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
Cancer Hallmarks
Webinars

Skip Nav Destination

Current Issue

Volume 5,

Issue 5

1 September 2024

View This Issue

About the Journal

Blood Cancer Discovery provides a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. Read More About the Journal

Editors-in-Chief

Riccardo Dalla-Favera
Kenneth C. Anderson

View Full Editorial Board

Impact Factor

11.7

SUBMIT TO JOURNAL

Featured Articles

Research Article

Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma

Leo Meriranta, et al.

Research Article

A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas

Federico Stella, et al.

Research Article

Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition

Martina Sarchi, et al.

Trending - Altmetric

The article titled, Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations., has an Alt Metric Attention Score of 6.85. Click to see more of this article's metrics.

Read the article titled, Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations.

Last mentioned on Sunday October 13 2024

The article titled, Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation, has an Alt Metric Attention Score of 7.1. Click to see more of this article's metrics.

Read the article titled, Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation

Last mentioned on Tuesday October 8 2024

Latest
Most Read
Most Cited

A Role for Germline Variants in Multiple Myeloma?

T Cell–Redirecting Bispecific Antibodies in Multiple Myeloma: Optimal Dosing Schedule and Duration of Treatment

Multiple Myeloma Risk and Outcomes are Associated with Pathogenic Germline Variants in DNA Repair Genes

Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations

Issues
Online First
News
Twitter

Online ISSN 2643-3249
Print ISSN 2643-3230

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Information on Advertising & Reprints
Information for Institutions/Librarians
RSS Feeds
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2023 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept